Harmony Biosciences secures $200 mln debt facility

OrbiMed Advisors has provided a $200 million debt facility to Plymouth Meeting, Pennsylvania-based Harmony Biosciences LLC, a pharmaceutical company focused on treating people living with rare diseases.